##gff-version 3
##sequence-region Q9NZL6 1 768
Q9NZL6	UniProtKB	Chain	1	768	.	.	.	ID=PRO_0000068885;Note=Ral guanine nucleotide dissociation stimulator-like 1	
Q9NZL6	UniProtKB	Domain	65	196	.	.	.	Note=N-terminal Ras-GEF;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00135	
Q9NZL6	UniProtKB	Domain	232	501	.	.	.	Note=Ras-GEF;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00168	
Q9NZL6	UniProtKB	Domain	648	735	.	.	.	Note=Ras-associating;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00166	
Q9NZL6	UniProtKB	Compositional bias	541	613	.	.	.	Note=Ser-rich	
Q9NZL6	UniProtKB	Modified residue	520	520	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q60695	
Q9NZL6	UniProtKB	Alternative sequence	1	9	.	.	.	ID=VSP_001824;Note=In isoform B. MKLLWQAKM->MEVKPVGEPTQEVSKFKLSTKVESTGHWLVEDHVRIWEVLKTEE;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:10760592,ECO:0000303|PubMed:15489334;Dbxref=PMID:10760592,PMID:15489334	
Q9NZL6	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_035823;Note=In a breast cancer sample%3B somatic mutation. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
Q9NZL6	UniProtKB	Natural variant	699	699	.	.	.	ID=VAR_035824;Note=In a breast cancer sample%3B somatic mutation. V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
Q9NZL6	UniProtKB	Sequence conflict	15	15	.	.	.	Note=W->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9NZL6	UniProtKB	Sequence conflict	687	687	.	.	.	Note=N->Y;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9NZL6	UniProtKB	Sequence conflict	761	761	.	.	.	Note=N->Y;Ontology_term=ECO:0000305;evidence=ECO:0000305	
